{"slug":"cspc-pharmaceutical-group","name":"석약집단(CSPC)","name_en":"CSPC Pharmaceutical Group","ticker":"1093.HK","updated_at":"2026-07-11T10:21:28.343+00:00","canonical":"https://valuechain.wiki/cspc-pharmaceutical-group","kicker":"항셍 지수","kicker_en":"Hang Seng Index","lead":"중국 대형 제약사로 항생제 원료의약품과 함께 항암·심혈관 등 완제 신약을 개발·생산하는 기업이다. 항셍 지수 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A large Chinese pharmaceutical group producing antibiotic APIs alongside branded oncology and cardiovascular drugs. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"완제의약품(신약)"},{"name":"항생제 원료"},{"name":"비타민C·기타 원료"}],"total":"약 ¥315억 (FY2023)"},"segments_en":{"parts":[{"name":"Finished drugs (innovative)"},{"name":"Antibiotics API"},{"name":"Vitamin C & other APIs"}],"total":"approx. CN¥31.5B (FY2023)"},"returns_yearly":{"2021":22.1,"2022":-3.6,"2023":-33.1,"2024":-18.4,"2025":120.9,"2026":-13.6},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}